Eltrombopag olamine

3′-{(2Z)-2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-yliden]hydrazino}-2′-hydroxy-3-biphenylcarbonsäure --2-aminoethanol (1:2)

3′-{(2Z)-2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2′-hydroxy-3-biphenylcarboxylic acid - 2-aminoethanol (1:2)

496775-62-3

4U07F515LG

[1,1′-Biphenyl]-3-carboxylic acid, 3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-, compd. with 2-aminoethanol (1:2)

Acide 3′-{(2Z)-2-[1-(3,4-diméthylphényl)-3-méthyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidène]hydrazino}-2′-hydroxy-3-biphénylcarboxylique - 2-aminoéthanol (1:2)

Eltrombopag olamine

Promacta

Revolade

496775-62-3 (olamine)

[1,1′-Biphenyl]-3-carboxylic acid, 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4-ylidene]hydrazino]-2′-hydroxy-, compd. with 2-aminoethanol (1:2)

Eltrombopag (SB497115) Olamine

MFCD22380664

SB-497115GR